SCHEMBL1822006

SCHEMBL1822006

NC(=S)Nc1ccc(O)cc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.65
GAA P10253 6/20 0.65
MAPT P10636 3/20 0.65
KDM4E B2RXH2 1/20 0.65
THRB P10828 1/20 0.65
L3MBTL1 Q9Y468 1/20 0.65
TSHR P16473 2/20 0.62
TP53 P04637 1/20 0.62
TYR P14679 1/20 0.62
TAS2R38 P59533 1/20 0.62
HSD17B10 Q99714 1/20 0.62
CYP3A4 P08684 2/20 0.61
CYP2D6 P10635 1/20 0.61
CYP2C9 P11712 1/20 0.61
HPGD P15428 1/20 0.61
ALOX12 P18054 1/20 0.61
CYP2C19 P33261 1/20 0.61
PEPD P12955 1/20 0.60
KMT2A Q03164 4/20 0.57
SMN1; SMN2 Q16637 2/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL725810 0.89 ALDH1A1 (0.75) ALDH1A1GAAMAPTKDM4ETHRB
SCHEMBL8705118 0.80 GAA (0.65) ALDH1A1GAAMAPTKDM4ETHRB
SCHEMBL728343 0.80 ALDH1A1 (0.62) ALDH1A1GAAMAPTL3MBTL1TSHR
SCHEMBL12071790 0.80 ALDH1A1 (0.62) ALDH1A1GAAMAPTKDM4ETHRB
SCHEMBL28916359 0.78 CA2 (0.60) ALDH1A1GAAMAPTKDM4ETHRB
SCHEMBL11751583 0.78 ALDH1A1 (0.61) ALDH1A1GAAMAPTL3MBTL1TSHR
SCHEMBL449122 0.78 ALDH1A1 (0.60) ALDH1A1GAAMAPTKDM4ETHRB
SCHEMBL526059 0.78 MAPT (0.63) ALDH1A1GAAMAPTKDM4ETSHR
SCHEMBL652231 0.78 IDO1 (0.63) ALDH1A1GAAMAPTTSHRTP53
SCHEMBL5518697 0.78 IDO1 (0.63) ALDH1A1GAAMAPTTSHRTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 133 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116730947-B 2,4, 5-Trisubstituted thiazole compound and preparation method and application thereof 广东省科学院微生物研究所(广东省微生物分析检测中心) 2024-07-02 CN claimed
CN-115449136-B Accelerator composition of rubber nanocomposite as well as preparation method and application thereof 浙江大学 2024-02-27 CN claimed
CN-116730947-A 2,4, 5-trisubstituted thiazole compound and preparation method and application thereof 广东省科学院微生物研究所(广东省微生物分析检测中心) 2023-09-12 CN claimed
CN-115449136-A Accelerator composition of rubber nanocomposite and preparation method and application thereof 浙江大学 2022-12-09 CN claimed
CN-114307994-A Preparation method and application of hydrogel adsorbent for Au (III) recovery 郑州大学 2022-04-12 CN claimed
CN-101993416-A Quinoline compound and preparation method thereof, medicament combination containing compound and application of compound SHANGHAI INST MATERIA MEDICA 2011-03-30 CN claimed
CN-107629022-B Antibacterial synergist and preparation method and application thereof 上海医药工业研究院 2024-11-12 CN disclosed
CN-116730947-B 2,4, 5-Trisubstituted thiazole compound and preparation method and application thereof 广东省科学院微生物研究所(广东省微生物分析检测中心) 2024-07-02 CN disclosed
CN-116730947-B 2,4, 5-Trisubstituted thiazole compound and preparation method and application thereof 广东省科学院微生物研究所(广东省微生物分析检测中心) 2024-07-02 CN disclosed
CN-115449136-B Accelerator composition of rubber nanocomposite as well as preparation method and application thereof 浙江大学 2024-02-27 CN disclosed
CN-116730947-A 2,4, 5-trisubstituted thiazole compound and preparation method and application thereof 广东省科学院微生物研究所(广东省微生物分析检测中心) 2023-09-12 CN disclosed
CN-116730947-A 2,4, 5-trisubstituted thiazole compound and preparation method and application thereof 广东省科学院微生物研究所(广东省微生物分析检测中心) 2023-09-12 CN disclosed
US-20230279426-A1 MODIFIED VIRAL COMPOSITIONS FOR VIRAL TRANSDUCTION LYCIA THERAPEUTICS, INC. 2023-09-07 US disclosed
WO-1992008721-A1 NOVEL CEPHALOSPORIN COMPOUNDS AND PROCESSES FOR PREPARATION THEREOF LUCKY, LTD. (KR) 1992-05-29 WO disclosed
EP-0397511-A2 Novel cephalosporin compounds and processes for preparation thereof LUCKY, LTD. (KR) 1990-11-14 EP disclosed
US-4816235-A Silver and manganese recovery using acidified thiourea PESIC BATRIC (US) 1989-03-28 US disclosed
US-4778519-A Recovery of precious metals from a thiourea leach PESIC BATRIC (US) 1988-10-18 US disclosed
US-4514346-A Method of making thermal-shock resistant molded articles on the basis of silicon carbide KERNFORSCHUNGSANLAGE JULICH GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1985-04-30 US disclosed
US-4293592-A Method for production of printed circuits by electroless metal plating HITACHI, LTD. (JP) 1981-10-06 US disclosed
US-3994719-A Resins for separating heavy metals consisting of thiourea-group-containing macroporous vinyl aromatic crosslinked matrixes BAYER AKTIENGESELLSCHAFT (DT) 1976-11-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230279426-A1 MODIFIED VIRAL COMPOSITIONS FOR VIRAL TRANSDUCTION HAVCR2, ASGR1, FCGR3B ALDH1A1 4368/4885GAA 1239/4885MAPT 2544/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.